Hyemi Lee

Suwon, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

A novel carboxamide bromodomain inhibitor attenuates osteoarthritis via epigenetic repression of NF-κB and MAPK signaling.

A novel carboxamide bromodomain inhibitor attenuates osteoarthritis via epigenetic repression of NF-κB and MAPK signaling.

Journal: Frontiers in immunology
Published: May 22, 2025

Tisochrysis lutea Fucoxanthin Suppresses NF-κB, JNK, and p38-Associated MMP Expression in Arthritis Pathogenesis via Antioxidant Activity.

Tisochrysis lutea Fucoxanthin Suppresses NF-κB, JNK, and p38-Associated MMP Expression in Arthritis Pathogenesis via Antioxidant Activity.

Journal: Antioxidants (Basel, Switzerland)
Published: June 25, 2024

A Novel BD2-Selective Inhibitor of BRDs Mitigates ROS Production and OA Pathogenesis.

A Novel BD2-Selective Inhibitor of BRDs Mitigates ROS Production and OA Pathogenesis.

Journal: Antioxidants (Basel, Switzerland)
Published: June 12, 2024

Blockade of the vaspin-AP-1 axis inhibits arthritis development.

Blockade of the vaspin-AP-1 axis inhibits arthritis development.

Journal: Experimental & molecular medicine
Published: May 02, 2024

Novel molecule BBC0901 inhibits BRD4 and acts as a catabolic regulator in the pathogenesis of osteoarthritis.

Novel molecule BBC0901 inhibits BRD4 and acts as a catabolic regulator in the pathogenesis of osteoarthritis.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 10, 2023

BRD2-specific inhibitor, BBC0403, inhibits the progression of osteoarthritis pathogenesis in osteoarthritis-induced C57BL/6 male mice.

BRD2-specific inhibitor, BBC0403, inhibits the progression of osteoarthritis pathogenesis in osteoarthritis-induced C57BL/6 male mice.

Journal: British journal of pharmacology
Published: June 25, 2023

Schisandra extract ameliorates arthritis pathogenesis by suppressing the NF-κB and MAPK signalling pathways.

Schisandra extract ameliorates arthritis pathogenesis by suppressing the NF-κB and MAPK signalling pathways.

Journal: Journal of cellular and molecular medicine
Published: February 17, 2023

Blockade of Activin Receptor IIB Protects Arthritis Pathogenesis by Non-Amplification of Activin A-ACVR2B-NOX4 Axis Pathway.

Blockade of Activin Receptor IIB Protects Arthritis Pathogenesis by Non-Amplification of Activin A-ACVR2B-NOX4 Axis Pathway.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 07, 2022

Synthesis of Novel (S)-3-(1-Aminoethyl)-8-pyrimidinyl-2-phenylisoquinolin-1(2H)-ones by Suzuki-Miyaura Coupling and Their Cell Toxicity Activities.

Synthesis of Novel (S)-3-(1-Aminoethyl)-8-pyrimidinyl-2-phenylisoquinolin-1(2H)-ones by Suzuki-Miyaura Coupling and Their Cell Toxicity Activities.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 03, 2021

Therapeutic Single Compounds for Osteoarthritis Treatment.

Therapeutic Single Compounds for Osteoarthritis Treatment.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 23, 2020

TRIM24-RIP3 axis perturbation accelerates osteoarthritis pathogenesis.

TRIM24-RIP3 axis perturbation accelerates osteoarthritis pathogenesis.

Journal: Annals of the rheumatic diseases
Published: May 07, 2020

3'-Sialyllactose prebiotics prevents skin inflammation via regulatory T cell differentiation in atopic dermatitis mouse models.

3'-Sialyllactose prebiotics prevents skin inflammation via regulatory T cell differentiation in atopic dermatitis mouse models.

Journal: Scientific reports
Published: December 11, 2019
Showing 1-12 of 16

Last Updated: 09/26/2026